Kenji Amagai
Kasama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Optimal Timing of Surgery Following Neoadjuvant Therapy for Surgical and Oncological Outcomes in Advanced Esophageal Squamous Cell Carcinoma: An Exploratory Analysis of JCOG1109.
Journal: Annals of surgical oncology
Published: October 14, 2025
RAS/BRAF wild-type metastatic high-methylated colorectal cancer has gene expression patterns related to MSI-H and BRAF V600E mutant: a translational research.
Journal: Scientific reports
Published: July 31, 2025
Estimation of Respiratory States Based on a Measurement Model of Airflow Characteristics in Powered Air-Purifying Respirators Using Differential Pressure and Pulse Width Modulation Control Signals-In the Development of a Public-Oriented Powered Air-Purifying Respirator as an Alternative to Lockdown Measures.
Journal: Sensors (Basel, Switzerland)
Published: March 29, 2025
First-line pembrolizumab plus chemotherapy for participants in Japan with gastric or gastroesophageal junction adenocarcinoma: subgroup analysis of the phase 3 KEYNOTE-859 study.
Journal: International journal of clinical oncology
Published: March 12, 2025
Fabrication of Two-Layer Aluminum Foam Consisting of Dissimilar Aluminum Alloys Using Optical Heating.
Journal: Materials (Basel, Switzerland)
Published: January 02, 2024
Efficacy of Pembrolizumab Monotherapy in Japanese Patients with Advanced Gastric or Gastroesophageal Junction Cancer.
Journal: Journal of gastrointestinal cancer
Published: February 08, 2023
Machine Learning Estimation of Plateau Stress of Aluminum Foam Using X-ray Computed Tomography Images.
Journal: Materials (Basel, Switzerland)
Published: January 18, 2023
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
Journal: Japanese journal of clinical oncology
Published: September 09, 2022
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer.
Journal: Cancer science
Published: March 04, 2022
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.
Journal: Japanese journal of clinical oncology
Published: November 29, 2021
A modified MethyLight assay predicts the clinical outcomes of anti-epidermal growth factor receptor treatment in metastatic colorectal cancer.
Journal: Cancer science
Published: November 20, 2021
Last Updated: 09/26/2026